Table V.

Adverse event rate.

Adverse events	Study group, n (%)	Control group, n (%)	P-value
Total	3/130 (2.31)	16/130 (12.31)	<0.05
Blood and lymphatic system disorders
Bone marrow suppression	0/130 (0.00)	6/130 (4.62)	<0.05
Gastrointestinal disorders
Abdominal pain	3/130 (2.31)	5/130 (3.85)	>0.05
Gastrointestinal reactions	0/130 (0.00)	3/130 (2.31)	>0.05
Hepatobiliary disorders
Compromised hepatic function	0/130 (0.00)	1/130 (0.77)	>0.05
Renal and urinary disorders
Compromised renal function	0/130 (0.00)	1/130 (0.77)	>0.05